AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Massive human-chain formed in Tirunelveli to combat drug abuse, alcoholism, and communal disharmony.
ByAinvest
Wednesday, Aug 13, 2025 12:32 pm ET1min read
A human-chain was organized by the Forum for Social Harmony in Tirunelveli, India, to raise awareness about drug abuse, alcoholism, and communal disharmony. Over 3,000 students and activists participated in the event, which was inaugurated by Assistant Collector Dhawlendu. The event aimed to foster communal harmony and promote a drug-free and alcohol-free society.
Eli Lilly (LLY.N) has recently launched its Mounjaro Kwikpen, a once-weekly injection device, in India. This move is part of the company's strategy to compete with Novo Nordisk (NOVOb.CO) in the market for weight-loss and diabetes management drugs. The launch follows a similar pen device launch by Novo Nordisk, Wegovy, in India.Mounjaro Kwikpen is available in six dose strengths ranging from 2.5 mg to 15 mg, with pricing varying from 14,000 to 27,500 rupees per month. The smallest doses are priced at 14,000 rupees and 17,500 rupees, while the 7.5 mg and 10 mg doses cost 22,000 rupees. The 12.5 mg and 15 mg doses are priced at 27,500 rupees [1].
Novo Nordisk's Wegovy, also a GLP-1 receptor agonist, has smaller doses ranging from 0.25 mg to 2.4 mg, priced between 17,345 to 26,015 rupees per month. The highest doses of Mounjaro are priced more competitively compared to Wegovy [1].
Lilly began selling Mounjaro in India in late March for diabetes and obesity management in 2.5 mg and 5 mg vials. Both drugs have seen strong demand since their launch, with sales in July doubling month-on-month [1].
The human-chain organized by the Forum for Social Harmony in Tirunelveli, India, aimed to raise awareness about drug abuse, alcoholism, and communal disharmony. The event, which saw participation from over 3,000 students and activists, was inaugurated by Assistant Collector Dhawlendu [2].
References:
[1] https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-launches-mounjaro-pen-india-160-starting-dose-stepping-up-novo-rivalry-2025-08-13/
[2] https://www.thehindu.com/news/cities/Madurai/human-chain-against-drug-abuse-alcoholism/article69929982.ece
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet